<DOC>
	<DOCNO>NCT01652859</DOCNO>
	<brief_summary>The 2 × 2 crossover design study evaluate bioequivalence two different liposomal amphotericin B injection single IV infusion dose normal healthy subject .</brief_summary>
	<brief_title>An Bioequivalence Study Compare Two 2 mg/ml Liposomal Amphotericin B Injections Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<criteria>1 . Subjects must adults ( &gt; 20 year old ) good health basis medical history , physical examination , electrocardiogram , chest Xray , routine laboratory evaluation . 2 . Vital sign ( 3 minute rest upright position ) within follow range : Ear body temperature 35.037.5 °C . Systolic blood pressure , 90140 mm Hg . Diastolic blood pressure , 5090 mm Hg . Pulse rate , 5090 bpm 3 . Fasting blood glucose &lt; 100 mg/dL . 4 . Body weight must 50 kg men 45 kg woman within 20 % ideal body weight . 5 . Negative urine drug screen clinic checkin dose 6 . Able sign inform consent prior study . 7 . Able communicate well investigator comply requirement study . 8 . Pregnancy test ( female ) : negative reaction 1 . Use prescription counter medication within 14 day prior investigational product administration ; exception acetaminophen ( 2 g/day ) vitamins . 2 . A plan take concomitant medication enrol study , exception acetaminophen ( 2 g/day ) vitamins . 3 . Presence acute chronic medical condition within 2 week prior investigational product administration , include limited : hepatic , gastrointestinal , renal , hematologic ( include coagulation ) , pulmonary , neurologic , respiratory , endocrine , cardiovascular system abnormality ; psychiatrical disease include major psychiatric disorder ( e.g. , schizophrenia , bipolar disorder ) ; acute infection ; condition would interfere absorption , distribution , metabolism , excretion drug . Evidence impair renal function indicate clinically significant abnormal creatinine BUN value abnormal urinary constituent ( e.g. , albuminuria ) judge investigator . Evidence liver disease , hepatitis B , hepatitis C liver injury indicate clinically significant abnormal liver function profile GOT , GPT , gGT , alkaline phosphatase , serum bilirubin , HBs Ag , HCV Ab judge investigator . 4 . Hemoglobin le 12 g/dL 5 . Participation clinical investigation within 2 month 5 halflives , whichever longer , prior investigational product administration . 6 . Donation loss 500 mL blood within 3 month prior investigational product administration . 7 . Subject know HIV infect . 8 . Known allergy hypersensitivity amphotericin B analog . 9 . History drug alcohol abuse within 12 month prior investigational product administration ; current consumption alcohol excess 28 units/week ( one unit 6 oz beer , ½ oz hard liquor , 2 oz wine ) 10 . Subjects , opinion investigator , participate study may capable follow study schedule reason . 11 . Consumption 36 40 oz ( 1.11.2 L ) caffeinecontaining beverage per day 12 . Consumption product contain grapefruit 3 day clinic checkin .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>